Highest-materiality recent filing
CareTrust REIT Q2 net income $89M, Normalized FFO $0.51 (+19% YoY); raises 2026 guidance
Net income $89.0M ($0.38 diluted EPS), up 9% YoY; Normalized FFO $119.7M ($0.51), up 19% YoY.
Underwriters exercised option in full for additional 1,875,000 shares at $40.225 per share.
CareTrust REIT closes $503M forward equity offering of 12.5M shares
Offering of 12.5M firm shares at $40.225 per share to underwriters; closing on May 20, 2026.
Q1 net income $80.2M ($0.36 diluted EPS); Normalized FFO $107.4M ($0.48/share, +14% YoY).
CareTrust REIT stockholders elect all director nominees, approve say-on-pay, ratify auditor
All six director nominees elected with >191M votes for each; against votes ranged from 86K to 4.4M.
CareTrust REIT updates investor presentation; no material new info disclosed
Company furnished updated investor presentation on its website under Regulation FD.
CareTrust REIT establishes new $1B ATM equity program; prior program terminated
New equity distribution agreement allows up to $1,000,000,000 in common stock sales at market prices.
CareTrust REIT Q4 net income up 72% YoY to $0.50 EPS; 2026 FFO guide $1.90-1.95
Q4 net income $111.3M ($0.50 diluted EPS), up 72% YoY; FY net income $320.5M ($1.57), up 96%.
CareTrust REIT adopts LTIP Units program for equity awards; directors and officers eligible
New LTIP Units created: Basic LTIP Units (time-vesting) and Performance LTIP Units (relative TSR-based).
CareTrust Q3 net income $74.9M +67%; normalized FFO $0.45; guidance updated
Net income $74.9M ($0.35 diluted EPS) up 67% YoY; normalized FFO $0.45 (+18%); normalized FAD $0.44 (+13%).
CareTrust REIT appoints former CEO Gregory Stapley to Board of Directors
Board increased from 5 to 6 directors; Stapley appointed effective Jan 1, 2026.
William Wagner retires as CFO/Treasurer effective Dec 31, 2025; will assist during transition.
CareTrust REIT closes 23M-share common stock offering at $32.00, gross proceeds ~$736M
Underwritten public offering of 20,000,000 firm shares plus 3,000,000 option shares at $32.00 per share.
CareTrust REIT Q2 net income $68.5M; normalized FFO $0.43/sh; guidance raised
Investments of $1.1B at 8.4% stabilized yield including acquisition of Care REIT plc.
CareTrust REIT adds $500M unsecured term loan facility, extends liquidity
Added $500M unsecured term loan facility maturing May 30, 2030, alongside existing $1.2B revolver.
CareTrust REIT posts updated investor presentation on its website
Updated presentation available under Events & Presentations tab at www.CareTrustREIT.com.
CareTrust closes acquisition of Care REIT plc for ~$840.5M total consideration
Target shareholders receive 108 pence per share (~$595.4M cash); plus assumption of ~$245.1M net debt.
CareTrust REIT Q1 normalized FFO $0.42; raises 2025 guidance; plans $856M Care REIT plc acquisition
Net income $65.8M ($0.35/sh); normalized FFO $0.42/sh; normalized FAD $0.43/sh.
CareTrust REIT's acquisition of Care REIT plc receives target shareholder approval
Care REIT plc shareholders approved the Scheme on April 29, 2025.
Five director nominees elected with at least 154.0M votes for each; broker non-votes of 12.2M.
CareTrust REIT to acquire Care REIT plc for $817M total enterprise value
Offer of 108 pence/share cash; 32.8% premium to Care REIT's March 10 closing price.
Q4 investments $696.5M at 9.9% stabilized yield; pipeline ~$325M; post-quarter investments $26.8M at 10.6%.
CareTrust REIT establishes new $750M at-the-market equity program
Up to $750M of common stock may be sold through sales agents or forward sellers.
CareTrust appoints Lauren Beale as CAO, promotes several, adds investment SVP
Lauren Beale promoted to CAO effective Jan 1, 2025; replaces William Wagner as principal accounting officer (Wagner remains CFO).
CareTrust REIT doubles unsecured revolver to $1.2B; S&P upgrades notes to BBB-
New $1.2B unsecured revolver (doubled from prior) matures Feb 2029, with two 6-month extension options.
CareTrust REIT raises $507.8M in public offering of 15.87M shares at $32/share
Offered 13.8M firm shares plus fully exercised 2.07M option shares for total 15.87M shares.
CareTrust REIT Q3 net income $33.4M; announces $500M Tennessee portfolio acquisition at 9.0% yield
Q3 net income $33.4M ($0.21 EPS); normalized FFO $0.38/sh; normalized FAD $0.39/sh.
CareTrust REIT JV agrees to acquire $500M skilled nursing portfolio; total pipeline $700M
31 facilities (3,290 beds) in Tennessee and Alabama; expected to close Q4 2024 in two phases.
CareTrust REIT establishes new $750M ATM equity program, replaces prior program
New equity distribution agreement allows issuance of up to $750M in common stock through at-the-market sales.
CareTrust REIT Q2 normalized FFO $0.36; YTD investments $764.5M at 9.5% yield
Net income $10.8M ($0.07 EPS); normalized FFO $52.5M ($0.36/share); normalized FAD $54.0M ($0.37/share).
CareTrust REIT updates investor presentation on website; no material new information
Updated investor presentation posted on Company website under 'Events & Presentations' tab.
CareTrust REIT enters $500M ATM equity distribution program, replacing prior program
New Equity Distribution Agreement allows sale of up to $500M in common stock through multiple agents and forward sellers.
CareTrust REIT Q1 net income $0.22/sh; normalized FFO $0.35/sh; dividend raised 3.6% to $0.29
Q1 net income $28.7M ($0.22/sh); normalized FFO $0.35/sh; normalized FAD $0.37/sh.
Five director nominees elected: Laing, Olson, Plumb, Sedgwick, Williams each received >104M votes for.
CareTrust REIT Q4 normalized FFO $0.36/sh; guides FY2024 FFO $1.43-$1.45
Q4 net income $26.3M ($0.22/sh); normalized FFO $43.4M ($0.36/sh); normalized FAD $45.4M ($0.37/sh).
CareTrust REIT Q3 normalized FFO $0.35/sh; invests $45.4M at 9.9% yield
Net income $8.7M ($0.08/sh); Normalized FFO $36.6M ($0.35/sh); Normalized FAD $38.8M ($0.37/sh).
CareTrust REIT enters new $500M at-the-market equity distribution program
New ATM program allows up to $500M in common stock sales through eight sales agents and forward sellers.
CareTrust REIT Q2 net loss $0.5M; normalized FFO $0.35/sh; acquired $173.5M
Net loss of $0.5M ($0.01/sh); normalized FFO $34.6M ($0.35/sh); normalized FAD $36.1M ($0.36/sh).
CareTrust REIT files 8-K noting updated investor presentation; no specific changes disclosed
Company indicates updated investor presentation is now available on its website.
CareTrust REIT Q1 normalized FFO $0.35/shr, dividend raised to $0.28, $47M acquisitions closed
Net income $19.2M ($0.19 EPS); normalized FFO $35.0M ($0.35/shr); normalized FAD $36.6M ($0.37/shr).
All five director nominees elected; David M. Sedgwick highest 'for' votes (81,139,728), Diana M. Laing most against (6,999,660).
CareTrust REIT enters new $500M ATM equity distribution program, terminates prior program
New equity distribution agreement for up to $500M in common stock sales through multiple agents and forward sellers.
CareTrust REIT Q4 normalized FFO $0.38; net income $14.4M; dividend maintained at $0.275
Q4 net income $14.4M ($0.15 diluted EPS); full-year net loss $7.5M ($0.08 loss).
CareTrust REIT renews unsecured revolver to $600M, extends maturity to 2027
$600M unsecured revolver and $200M term loan under amended credit agreement.
CareTrust REIT appoints James Callister as CIO, effective Dec 31, 2022
Mark Lamb resigns as CIO, effective Dec 31, to pursue entrepreneurial opportunities.
CareTrust REIT Q3 normalized FFO $0.37/share, net income $0.7M, dividend $0.275 maintained
Net income $0.7M ($0.01 EPS); normalized FFO $36.1M ($0.37/share); normalized FAD $38.0M ($0.39/share).
CareTrust REIT Q2 net income $20.7M, normalized FFO $35.6M, collects 93.9% of rents
Net income $20.7M ($0.21/diluted EPS); Normalized FFO $35.6M ($0.37/share); Normalized FAD $37.5M ($0.39/share).
CareTrust REIT board changes: Stapley resigns, Sedgwick appointed, Laing named Chair
Greg Stapley resigned as Executive Chairman and from the Board, effective June 28, 2022, to begin missionary service.
CareTrust REIT to transfer stock listing from Nasdaq to NYSE effective May 23, 2022
Voluntarily delists from Nasdaq at close of trading May 20, 2022; begins trading on NYSE on May 23, 2022 under same ticker CTRE.
CareTrust Q1 net loss $43.3M on $59.7M impairments; normalized FFO up 5.2%
Net loss of $43.3M ($0.45 diluted loss) due to $59.7M impairments on assets held for sale.
The Board of Directors of CareTrust REIT, Inc., a Maryland corporation (the “Company”), promoted Lauren Beale to the position of Senior Vice President, Chief Accounting Officer of the Company effective as of January 1, 2025, to serve until her successor is duly elected and qualifies.
On November 21, 2022, Mark D. Lamb, a named executive officer, notified CareTrust REIT, Inc. (the “Company”) of his resignation as Chief Investment Officer of the Company, effective December 31, 2022.
On June 27, 2022, Greg Stapley, former Chief Executive Officer and current Executive Chairman of the Board of Directors (the “Board”) of CareTrust REIT, Inc. (the “Company”), resigned as a member of the Board, effective June 28, 2022.
On June 28, 2022, the Board appointed David Sedgwick, the Company’s current President and Chief Executive Officer, to the Board, effective immediately following Mr. Stapley’s resignation from the Board on June 28, 2022.
Also on June 28, 2022 and in connection with the appointment of Mr. Sedgwick to the Board, Diana Laing, current Lead Independent Director of the Board, was appointed to serve as independent Chair of the Board, effective immediately following Mr. Stapley’s resignation from the Board on June 28, 2022, and ceased serving as Lead Independent Director on that date.
On March 10, 2022, Allen Barbieri notified CareTrust REIT, Inc. (the “Company”) in writing of his decision to resign as a member of the Company’s Board of Directors, effective immediately.
On March 14, 2022, the Board of Directors unanimously appointed Ms. Careina D. Williams to the Board of Directors, effective immediately.
On December 9, 2021, the Board of Directors appointed Diana M. Laing as Lead Independent Director.
On December 9, 2021, Greg Stapley notified CareTrust REIT, Inc. (the “Company”) of his resignation as Chief Executive Officer (“CEO”) of the Company, effective January 1, 2022.
Also on December 9, 2021, the Board of Directors of the Company appointed David Sedgwick, the Company’s current President and Chief Operating Officer, as CEO, effective January 1, 2022.
Max materiality 0.90 · Median 0.62 · Most common event earnings